Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

New Drug Application For Exenatide Once Weekly Accepted For Review By FDA
Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) announced that the New Drug Application (NDA) for exenatide once weekly has been accepted for review by the U.S. Food and Drug Administration (FDA).

FDA Approves Reclast(R) To Prevent Osteoporosis In Postmenopausal Women With Convenient Less Frequent Dosing
Reclast® (zoledronic acid 5 mg) Injection* has been approved by
News of the day
Athletes, Spectators Faced Unprecedented Air Pollution At 2008 Olympic Games
Particulate air pollution during the 2008 Olympic Games in Beijing constantly exceeded levels considered excessive by the World Health Organization, was far worse than other recent Olympic Games, and was about 30 percent higher than has been reported by Chinese environmental experts - even though some favorable weather conditions helped reduce the problem.
Medical Devices

DFine Europe GmbH Accepts Terms Of Preliminary Injuction Issued By German Court For Medtronic GmbH

Medtronic, Inc. announced that DFine Europe GmbH has accepted the terms of a preliminary injunction granted to Medtronic GmbH by a German Competition Court. The preliminary injunction stops DFine Europe GmbH from using certain misleading marketing claims related to Medtronic"s Kyphon® Balloon Kyphoplasty products in Germany. On May 19, 2009, a German Competition Court issued a preliminary injunction for Medtronic GmbH against DFine Europe GmbH (District Court of Cologne, court file no. 33 0 147/09). With this preliminary injunction, DFine Europe GmbH was ordered to refrain from using certain promotional claims comparing its bone cement StabiliT™ ER2 to Medtronic"s KyphX® HV-R™ Bone Cement (now known as KYPHON® HV-R® Bone Cement). A preliminary injunction under German law provides the claimant with the option to ask a competition court to issue a preventive measure against assumed anti-competitive behavior, including illegal advertising. DFine Europe GmbH has accepted the terms of the preliminary injunction as binding. Medtronic


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009